Your browser doesn't support javascript.
loading
Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma.
Thomson, Alice; Castillo, Carlotta; Graefen, Henrike; Perera, Sachin; Lawrentschuk, Nathan; Perera, Marlon; Eapen, Renu; Murphy, Declan G.
Afiliação
  • Thomson A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Castillo C; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Santiago Clinic Hospital, Santiago de Compostela, Spain.
  • Graefen H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Medical School Hamburg, Hamburg, Germany.
  • Perera S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
  • Perera M; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Eapen R; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. Electronic address: declan.murphy@petermac.org.
Eur Urol ; 2024 Apr 16.
Article em En | MEDLINE | ID: mdl-38631995

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Urol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália